Abuse deterrent morphine sulfate dosage forms

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 12161754
APP PUB NO 20200337994A1
SERIAL NO

16337743

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a solid oral extended release pharmaceutical dosage form comprising a cured extended release matrix formulation, the extended release matrix formulation comprising:

    a therapeutically effective amount of morphine sulfate, andpolyethylene oxide.The invention further relates to a process of preparing the dosage form as well as to a method of treating pain by administering the dosage form.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PURDUE PHARMA L PONE STAMFORD FORUM 201 TRESSER BOULEVARD STAMFORD CT 06901

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huang, Haiyong Hugh Princeton Junction, US 31 203

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 10, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 10, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 10, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00